Micro-X Ltd
ASX:MX1
Micro-X Ltd
ASX:MX1
Price:
0.087 AUD
-2.79%
Market Closed
Updated:
May 21, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-3
Current
-4.8
Median
13.1
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-3
Enterprise Value
/
43.4m
EBITDA
-14.3m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| AU |
|
Micro-X Ltd
ASX:MX1
|
45.1m AUD | -3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
179.5B USD | 18.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.9B USD | 58.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.6B USD | 24.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.4B USD | 14.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.8B USD | 31.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.9B USD | 18.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 18.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54B USD | 27.8 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.8B USD | 60.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
370.2B CNY | 28 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
-5
2-Years Forward
EV/EBITDA
-13.4
3-Years Forward
EV/EBITDA
-53.7
You don't have any saved screeners yet
